JPM26: ThermoFisher ‘very positive’ on strategic M&A as deals expand capabilities
ThermoFisher Scientific plans to drive share gain, pursue targeted mergers and acquisitions (M&A), and strengthen its end-to-end offering for pharmaceutical and biotechnology customers, CEO Marc N. Casper said at the 44th Annual JP Morgan Healthcare …